News

In his debut blog, Zack Oakey, MD, defends Sen. Rand Paul's actions against the American Board of Ophthalmology, and challenges his colleagues to do the same.

With the vast of information available online these days, it is only natural to want to search via ‘Google’ a past or current love, or even a potential employer to find out more about them. Patients also tend to search the Internet for physician recommendations-or negative comments-before choosing the right doctor for their ailment.But do physicians do the same for their patients? More importantly, is that even an acceptable practice?

Implant exchange in multifocal IOL recipients unhappy with their vision is better performed sooner rather than later. It is even better to avoid the exchange whenever possible by identifying and addressing a treatable cause for the patient’s complaints.The best strategy of all is to prevent dissatisfaction in the first place by attention to patient selection and preoperative management, said Stephen G. Slade, MD.

Dr. Heier, professor of ophthalmology, Tufts University School of Medicine and Harvard University Medical School, Boston, evaluated the currently used regimens to determine the ideal approaches for these patients.

In patients with the rare disease of tumefactive multiple sclerosis, brain lesions may be mistaken for tumors. Treatments of high-dose steroid therapy and plasmapheresis can be considered.

Postmarketing clinical experience with ocriplasmin shows treatment success is higher when patients are chosen based on ideal criteria. No safety signals have emerged, but safety is being investigated more closely in ongoing trials.

Patients treated with aflibercept intravitreal injections for macular edema associated with branch retinal vein occlusion had a significantly greater decrease in central retinal thickness and significantly greater improvement in vision compared with laser at the end of the 52-week VIBRANT trial.

Studies that focus on switching treatments for exudative age-related macular degeneration may represent more real-life scenarios. However, future prospective studies with predetermined switching criteria and follow-up are needed.

An analysis of independent data published in AREDS Report 38 shows that the response of patients with moderate to advanced age-related macular degeneration (AMD) to treatment with zinc or the Age-Related Eye Disease Study (AREDS) formulation varied substantially based on genotype.

Sheldon Silver was, until recently, Speaker of the New York State Assembly. This post made him one of that state's two or three most powerful political figures. He was forced to resign his post when indicted for corruption.

Social media platforms are popular, multiplying, and potentially a way to reach patients with reliable information that could help build doctor-patient relationships and improve adherence to glaucoma medication.

Aflibercept is reportedly superior to ranibizumab and bevacizumab when treating some patients with diabetic macular edema (DME), according to a National Institutes of Health (NIH)-sponsored clinical trial.

Highly variable myopia shifts can occur in pseudophakic children. IOL exchange seems to be an acceptable option for treating the high myopia that can develop with lens implantation in children.However, the use of IOLs in growing eyes remains controversial, and outcomes are uncertain because of lack of data, according to Courtney Kraus, MD.